Fig. 7From: Enhanced in vivo blood brain barrier transcytosis of macromolecular cargo using an engineered pH-sensitive mouse transferrin receptor binding nanobodyDiagram of hypothesized mechanisms involved in BBB transcytosis of mTfR-and-P2X7-receptor binding nanobody constructs. Anti-mTfR nanobodies bind to mTfR in blood and constructs are endocytosed. Nanobody constructs unbind from mTfR in a pH-dependent fashion in intracellular vesicular compartments. Nanobody constructs are released into the brain and bind P2X7 receptor targets. (Produced using BioRender)Back to article page